4.7 Article

The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Gastroenterology & Hepatology

Osteopontin Takes Center Stage in Chronic Liver Disease

Zhuolun Song et al.

Summary: Despite being initially discovered in bone, osteopontin (OPN) is expressed in other tissues as well. In addition to its well-established physiological roles, research suggests that OPN is also involved in chronic liver disease.

HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis

Changyu Zhu et al.

Summary: Emerging data suggest that the reactivation of developmental pathways is associated with nonalcoholic steatohepatitis (NASH) and fibrosis in the liver injury response. This review discusses the role of these pathways in liver development and in the pathogenesis of NASH and fibrosis.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Medicine, General & Internal

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

Arun J. Sanyal et al.

Summary: In this study involving patients with nonalcoholic fatty liver disease, advanced fibrosis stages F3 and F4 were associated with increased risks of liver-related complications and death over a median of 4 years of follow-up. Advanced fibrosis was also related to an increased incidence of liver decompensation events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Cell Biology

Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication

Anne Loft et al.

Summary: Liver fibrosis is a strong predictor of long-term mortality in individuals with metabolic-associated fatty liver disease. The study shows comprehensive alterations in hepatocyte genomic and transcriptional settings during NASH progression, leading to a loss of hepatocyte identity. The reprogramming of hepatocytes is under tight cooperative control of a network of fibrosis-activated transcription factors, promoting hepatocyte dysfunction and directing intra-hepatic crosstalk necessary for NASH and fibrosis progression.

CELL METABOLISM (2021)

Review Biochemistry & Molecular Biology

Annexin A2 in Fibrinolysis, Inflammation and Fibrosis

Hana Lim et al.

Summary: Annexin A2 complex plays a crucial role in hemostasis and fibrinolysis on endothelial cell surface; Aberrant expression of A2 is associated with various diseases including thrombosis and inflammation; Dysregulation of A2 function may impact wound healing and tissue fibrosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Immunology

Recombinant annexin A2 inhibits peripheral leukocyte activation and brain infiltration after traumatic brain injury

Ning Liu et al.

Summary: Systematic administration of rA2 at 2 hours post-TBI significantly inhibits activation and brain infiltration of peripheral leukocytes, especially neutrophils, during the acute phase. rA2 binds to neutrophils and reduces TLR4 expression, suppressing the NF kappa B signaling pathway. This leads to reduced neuroinflammation, neurodegeneration, and long-term improvements in sensorimotor ability and cognitive function after TBI.

JOURNAL OF NEUROINFLAMMATION (2021)

Article Gastroenterology & Hepatology

New drugs for NASH

Somaya A. M. Albhaisi et al.

Summary: NASH is a form of liver disease characterized by inflammation and hepatocyte injury in the presence of hepatic steatosis, potentially leading to cirrhosis. Although weight loss and lifestyle modifications are currently the first-line treatment, the development of effective drugs for NASH is urgently needed as these methods may not be effective in advanced cases. There has been significant growth in drug development targeting pathological pathways in NASH in the past decade.

LIVER INTERNATIONAL (2021)

Article Cell Biology

Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis

Junjie Yu et al.

Summary: Elevated hepatocyte Jagged1 expression plays a crucial role in Notch-induced liver fibrosis in NASH. Inhibition of Jagged1 may serve as a potential therapeutic target for patients with NASH.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Medicine, General & Internal

Nonalcoholic Steatohepatitis: A Review

Adam C. Sheka et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Cell Biology

Anxa2 gene silencing attenuates obesity-induced insulin resistance by suppressing the NF-κB signaling pathway

Yong Wang et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)

Article Gastroenterology & Hepatology

Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis

Wenli Liu et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Cell & Tissue Engineering

Chronic Liver Injury Induces Conversion of Biliary Epithelial Cells into Hepatocytes

Xing Deng et al.

CELL STEM CELL (2018)

Article Gastroenterology & Hepatology

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

Zobair M. Younossi

LIVER TRANSPLANTATION (2018)

Review Gastroenterology & Hepatology

Involvement of epithelial-mesenchymal transition in liver fibrosis

Kangkang Yu et al.

SAUDI JOURNAL OF GASTROENTEROLOGY (2018)

Article Cell Biology

Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis

Changyu Zhu et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Article Biochemistry & Molecular Biology

Osteopontin regulates the cross- talk between phosphatidylcholine and cholesterol metabolism in mouse liver

Maitane Nunez-Garcia et al.

JOURNAL OF LIPID RESEARCH (2017)

Review Medicine, General & Internal

Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

Anna M. Diehl et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Biochemistry & Molecular Biology

Protein phosphorylation and its role in the regulation of Annexin A2 function

Ann Kari Grindheim et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)

Article Gastroenterology & Hepatology

Annexin A2 promotes liver fibrosis by mediating von Willebrand factor secretion

Min Yang et al.

DIGESTIVE AND LIVER DISEASE (2017)

Review Gastroenterology & Hepatology

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

Chong-Yang Zhang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Serum Levels of Annexin A2 as a Candidate Biomarker for Hepatic Fibrosis in Patients With Chronic Hepatitis B

Servet Kolgelier et al.

HEPATITIS MONTHLY (2015)

Article Biochemical Research Methods

High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers

Ingmar Mederacke et al.

NATURE PROTOCOLS (2015)

Article Gastroenterology & Hepatology

Osteopontin Contributes to TGF-β1 Mediated Hepatic Stellate Cell Activation

Xiao Xiao et al.

DIGESTIVE DISEASES AND SCIENCES (2012)

Article Multidisciplinary Sciences

Annexin A2 Is a Natural Extrahepatic Inhibitor of the PCSK9-Induced LDL Receptor Degradation

Nabil G. Seidah et al.

PLOS ONE (2012)

Article Biochemistry & Molecular Biology

Plasma membrane proteome analysis of the early effect of alcohol on liver: implications for alcoholic liver disease

Lijun Zhang et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2011)

Article Hematology

Annexin A2 tetramer activates human and murine macrophages through TLR4

Jennifer F. A. Swisher et al.

Article Biochemistry & Molecular Biology

Annexin A2 Is a C-terminal PCSK9-binding Protein That Regulates Endogenous Low Density Lipoprotein Receptor Levels

Gaetan Mayer et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Gastroenterology & Hepatology

Disruption of tissue-type plasminogen activator gene in mice aggravated liver fibrosis

Yao Hsiao et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)

Article Cell Biology

Annexin A2 is a soluble mediator of macrophage activation

Jennifer F. A. Swisher et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2007)

Article Biochemistry & Molecular Biology

A human hepatocellular in vitro model to investigate steatosis

Maria Jose Gomez-Lechon et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2007)

Article Gastroenterology & Hepatology

Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model

A Sahai et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)